همبستگی عزت نفس با پیشرفت تحصیلی در دانشجویان دانشکده‌ی پرستاری و مامایی زنجان 1388

زمینه و هدف: یکی از بزرگترین معضلات آموزشی، افت تحصیلی دانشجویان است. بنابراین توجه به بهداشت روانی و پیشرفت تحصیلی این گروه اهمیت به‌سزایی دارد. پاره‌ای از مطالعات بیانگر ارتباط مستقیم بین عزت نفس و پیشرفت تحصیلی است، لیکن بعضی از صاحب نظران رابطه‌ی مستقیم این دو را مورد تردید قرار داده‌اند. این پژوهش با هدف تعیین همبستگی عزت نفس با پیشرفت تحصیلی دانشجویان دانشکده‌ی پرستاری و مامایی زنجان انجام شده است. روش بررسی: این پژوهش یک مطالعه‌ی همبستگی بود، کلیه‌ی دانشجویان دانشکده‌ی پرستاری و مامایی زنجان که حداقل دو نیم‌سال سابقه‌ی تحصیلی داشتند، (182 نفر) در مطالعه شرکت کردند. ابزار جمع‌آوری اطلاعات پرسش‌نامه بود. پرسش‌نامه از دو بخش شامل: ویژگی‌های فردی و تحصیلی واحدهای پژوهش و آزمون 58 سوالی عزت نفس کوپراسمیت تشکیل شده بود. یافته‌ها: ضریب همبستگی پیرسون رابطه‌ی معنی‌داری بین عزت نفس و پیشرفت تحصیلی دانشجویان نشان داد (31/0= r ). ولی عزت نفس با سن و جنسیت ارتباط آماری معنی‌داری نداشت (05/0 P ). نتیجه‌گیری: با توجه به وجود همبستگی مثبت بین عزت نفس و پیشرفت تحصیلی دانشجویان، به نظر می‌رسد استفاده از روش‌های تقویت عزت نفس می‌تواند در جلوگیری از افت تحصیلی دانشجویان نقش داشته باشد

Intravenska trombolitična terapija pomoću rt-PA u pedeset šestoro bolesnika s ishemijskim moždanim udarom - prospektivna studija praćenja

Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) has recently reached the goal of becoming standard therapy in the acute stage of ischemic stroke in many countries. This appears to be one of the first pilot study reports from the region of Central and Eastern Europe. From January 1998 till October 2002, 56 consecutive patients underwent rt-PA thrombolysis at the University Department of Neurology, Nitra University Hospital, Slovakia. Selection criteria for the study were based on the NINDS study, with emphasis on the 3-hour therapeutic window. The mean baseline NIHSS wasR14.5, mean therapeutic interval 167 minutes, and mean intravenous rt-PA dose 0.7 mg/kg body weight. AtR3 months, mRS 0-1 was recorded in 33.9%, mRS 2-3 in 37.5%, and mRS 4-5 in 16.1% of study patients. Clinically relevant mRS 0-2 was achieved in 44.6% of study patients. The mortality was 12.5%. The rate of symptomatic and fatal intracerebral hemorrhage was 8.9% and 5.3%, respectively. Asymptomatic hemorrhagic transformation of a benign course was relatively frequently recorded (19.6%). Results of the study showed our stroke patients treated with intravenous rt-PA to have a favorable prognosis, and were comparable with those reported from the NINDS study and recent clinical studies.Intravenska tromboliza pomoću rekombinantnog aktivatora tkivnog plazminogena (rt-PA) odnedavno je postigla svoj cilj i u mnogim zemljama postala standardnim načinom liječenja akutnog stadija ishemijskog moždanog udara. Ovo je, čini se, jedno od prvih objavljenih probnih ispitivanja u području središnje i istočne Europe. U razdoblju od siječnja 1998. do listopada 2002. godine je na Klinici za neurologiju Sveučilišne bolnice Nitra iz Nitre, Slovačka, 56 uzastopnih bolesnika podvrgnuto trombolizi. Kriteriji za odabir bolesnika zasnivali su se na studiji NINDS, poglavito terapijski prozor od 3 sata. Postignuli smo prosječan bazalni NIHSS od 14,5, prosječan terapijski interval bio je 167 minuta, a prosječena doza intravenskog rt-PA bila je 0,7 mg/kg tjelesne težine. Nakon 3 mjeseca mRS 0-1 dostignulo je 33,9%, mRS 2-3 37,5%, te mRS 4-5 16,1% bolesnika. Klinički važan mRS 0-2 postiglo je 44,6% bolesnika. Smrtnost je bila 12,5%. Stopa simptomatskog unutarmoždanog krvarenja bila je 8,9%, a fatalnog 5,3%. Asimptomatska hemoragijska transformacija bila je relativno česta, tj. u 19,6% bolesnika s benignim tijekom. Zaključeno je kako bolesnici s moždanim udarom koji se liječe intravenskom rt-PA trombolizom u našoj bolnici imaju dobru prognozu, usporedivu s rezultatima studije NINDS i drugim novijim kliničkim studijama

Leaving a legacy of stroke in Europe: A community of dedicated professionals is changing the face of stroke in Europe

Time is of the essence in the treatment of acute stroke; however, there are wide variations, across and within countries, in the ability to hospitalize, scan, diagnose, and treat acute stroke patients rapidly within the accepted time window of 4.5 hours. Door-to-needle (DTN) time is an important performance indicator that illustrates the speed and operational efficiency of stoke units. Significant progress is being made; DTNs often exceeded an hour only a few years ago, but can now be achieved in under seven minutes in leading stroke units. This symposium examined the strategies and contributory factors that result in reduced DTN times, and how these strategies can be more widely implemented. The Quality in Acute Stroke Care (QASC) programme in Australia has shown the incorporation of standardized nurse-led treatment protocols for the management of fever, hyperglycaemia, and dysphagia (FeSS protocols) significantly improve outcomes for stroke patients. European evaluation of these protocols, in collaboration with ESO and the ANGELS initiative, and potentially leading to their adoption in European acute stroke treatment practice is discussed

Factors Influencing In-Hospital Delay in Treatment With Intravenous Thrombolysis

Background and Purpose-Shortening door-to-needle time (DNT) for the thrombolytic treatment of stroke can improve treatment efficacy by reducing onset-to-treatment time. The goal of our study was to explore the association between DNT and outcome and to identify factors influencing DNT to better understand why some patients are treated late

Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke

Background and Purpose-A recent meta-analysis investigating the association between statins and early outcomes in acute ischemic stroke (AIS) patients treated with intravenous thrombolysis (IVT) indicated that prestroke statin treatment was associated with increased risk of 90-day mortality and symptomatic intracranial hemorrhage. We investigated the potential association of statin pretreatment with early outcomes in a large, international registry of AIS patients treated with IVT

Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke

Background and Purpose-A recent meta-analysis investigating the association between statins and early outcomes in acute ischemic stroke (AIS) patients treated with intravenous thrombolysis (IVT) indicated that prestroke statin treatment was associated with increased risk of 90-day mortality and symptomatic intracranial hemorrhage. We investigated the potential association of statin pretreatment with early outcomes in a large, international registry of AIS patients treated with IVT